Performance snapshot
eKreative presents as a well-established offshore development partner with a strong track record across custom software, web, and mobile app development. The review profile is dominated by consistently high ratings, with most categories scoring Strong, supported by multiple high-density reviews citing specific metrics, named technologies, and long-term engagement histories. A minor recurring theme around holistic technical advisory and early-stage planning depth introduces slight nuance to an otherwise highly positive picture. The vendor's longevity with clients — several partnerships spanning five to ten-plus years — underscores consistent delivery and trust.
Best for
eKreative is best suited for SMBs and digital agencies seeking a reliable offshore development partner for custom software, web, and mobile applications. They excel at long-term staff augmentation, MVP development, and full-stack builds requiring cross-timezone collaboration.
Clients info
eKreative serves a broad client base spanning technology, marketing, media, financial services, and retail sectors. Clients are predominantly small-to-mid-sized businesses and digital agencies, with several engagements involving enterprise-level organizations. Project budgets range widely from under $50,000 for MVP or augmentation work to multi-million-dollar long-term development partnerships. Primary industries represented include Information Technology, Advertising & Marketing, Media & Streaming, Financial Services, Retail & Nutrition, Healthcare & Medical Devices. Typical client size bands include 1-10 Employees, 11-50 Employees, 10,001+ Employees (enterprise, isolated). Common project budget ranges include $10,000 to $49,999, $50,000 to $199,999, $200,000 to $999,999, $1,000,000 to $9,999,999.
Review strength
The assessment is based on 27 reviews across 3 platforms. The majority of reviews are from one structured review platform, supplemented by a professional services directory and general user reviews. Most reviews date from 2019 to 2021, with only one review from 2023, meaning the bulk of the evidence is now over three years old and should be interpreted with appropriate recency caution. Review date range: Jan 13, 2020 - 26 July, 2023.